+ All Categories
Home > Documents > Cardio_IE

Cardio_IE

Date post: 03-Jun-2018
Category:
Upload: phoenix24601
View: 215 times
Download: 0 times
Share this document with a friend

of 39

Transcript
  • 8/12/2019 Cardio_IE

    1/39

  • 8/12/2019 Cardio_IE

    2/39

    HPI

    67 caucasian male

    CC: Chest pain

    Chest pain was 10/10 in severity, woke him up

    from sleep, dull, nonradiating No palpitations, SOB, diaphoresis, nausea or

    vomiting

    EMS called En route given ASA and NTG which did not

    provide relief of symptoms

  • 8/12/2019 Cardio_IE

    3/39

    PAST MEDICAL HISTORY

    Aortic valve stenosis s/p aortic valve replacement(bioprosthetic) in 2011

    BPH

    s/p bilateral inguinal herniorrhapy

    MEDICATIONS

    Aspirin, Flomax, Naproxen, Flexeril NKDA

  • 8/12/2019 Cardio_IE

    4/39

    FAMILY HISTORY (+) heart diseasegrandmother, diagnosed at age 75

    SOCIAL HISTORY Married, retired employee, nonsmoker, drinks wine

    occasionally

  • 8/12/2019 Cardio_IE

    5/39

    Review of systems

    No nasal congestion or sore throat

    No cough or SOB

    No abdo pain, nausea or vomiting

    (+) Diarrhea x 2 days

    No dysuria or hematuria

    No weight loss or weight gain

    No headache or dizziness

    (+) chills but no documented fever

  • 8/12/2019 Cardio_IE

    6/39

    Physical Exam

    T-36.2, BP-94/57, HR-104, RR-20, sats 98% RA

    Alert and oriented x 3

    Supple neck, no lymphadenopathy

    Lungs: CTAB Heart: S1S2, regular rhythm, tachycardic, no

    murmur/rubs/gallops

    Abdomen: soft, nontender, nondistended, bowel sounds

    heard No pedal edema/cyanosis/clubbing, good peripheral

    pulses

    Neuro exam nonfocal

  • 8/12/2019 Cardio_IE

    7/39

    Labs

    BMP

    Na 141

    K 4.3

    Cl 102

    CO2 25

    BUN 13

    Crea 0.9

    Glucose 92

    Ca 8.6AG 14

    CBC

    Hb 13.1

    Hct 38.9

    WBC 15.7

    Plt 178

    Neut 78%

    Lymp 9%

    Trop I 0.026

    INR 1.12

    BNP 706

  • 8/12/2019 Cardio_IE

    8/39

    EKG

  • 8/12/2019 Cardio_IE

    9/39

    CXR

  • 8/12/2019 Cardio_IE

    10/39

    Cath Report

    LVEF > 60%

    LMCANo obstructing lesions

    LAD

    No obstructing lesions LCXProximal third obtuse marginal artery

    was 100% occluded

    RCA

    dominant to the posterior circulation.No obstructing lesions.

  • 8/12/2019 Cardio_IE

    11/39

    Hospital Course

    Concern for possible pericarditis

    ESR 34, CRP 14.5

    ID consulted: Suspect viral pericarditis

    Influenza A and B - negative

    Mycoplasma pneumoniae PCR - negative

    Stool for C. Diff - negative

  • 8/12/2019 Cardio_IE

    12/39

    Transthoracic Echo

    LVEF 68%

    Mild MR

    Bioprosthetic aortic valve prosthesis. It is well-seated with no perivalvular regurgitation.

    Mean TVG 12.68.

    No evidence of pericardial effusion

  • 8/12/2019 Cardio_IE

    13/39

    Hospital Course

    Blood Culture (1stset) Prelim report

    Bottle I: Gr (+) cocci in pairs and chains

    Bottle II: Gr (+) organisms

    ID started Gentamicin + Zyvox + Unasyn while

    waiting for final blood culture report

    Blood Culture (1stset) Final report

    Streptococcus viridans

    ID shifted Abx to Ceftriaxone + Gentamicin

  • 8/12/2019 Cardio_IE

    14/39

    TEE

    Normal LV size and systolic function with LVEF 55-60%

    No evidence of thrombus in the left atrial body orappendage

    No spontaneous echo contrast in the LA

    Aortic valve bioprosthesis is well-seated. Novegetations, perivalvular leaks or abscessformation. No AR. No AS. MG 23. AVA 1.3.

    Pericardium is normal. No significant pericardialeffusion

  • 8/12/2019 Cardio_IE

    15/39

    Hospital Course

    2ndand 3rdsets of Blood Culture also showed

    growth of Strep viridans.

    4thset of Blood Culture: No growth

    PICC line inserted

    Discharged on Ceftriaxone (6 weeks) +

    Gentamicin (2-6 weeks)

    Repeat TEE in 2 weeks

  • 8/12/2019 Cardio_IE

    16/39

    Infective Endocarditis

  • 8/12/2019 Cardio_IE

    17/39

  • 8/12/2019 Cardio_IE

    18/39

  • 8/12/2019 Cardio_IE

    19/39

    Physical Exam

  • 8/12/2019 Cardio_IE

    20/39

    Blood Cultures

    Should be obtained prior to antibiotic therapy

    Minimum of three blood cultures

    Not all organisms have the same propensity to cause endocarditis

    Typical causes of IE

    Staphylococcus aureus

    Viridans streptococci and Streptococcus bovis Enterococci

    HACEK group organisms

    For an organism likely to cause endocarditis (eg, S. aureus, viridansstreptococci), twopositive samples collected more than 12 hoursapart

    For an organism that is more commonly a skin contaminant,threeor a majority of four or more separate blood cultures arepositive and the first and last samples are collected at least onehour apart

  • 8/12/2019 Cardio_IE

    21/39

    Echocardiogram

    An echocardiogram should be performed in allpatients with a moderate or high suspicion of

    endocarditis

    TTE: relatively low sensitivity (29-63%), specificity

    approaches 100%

    TEE:

    higher sensitivity than TTE (100% vs 63%, 94% vs 44%)

    especially important for prosthetic valves in the mitral

    or aortic position

    more sensitive than TTE for the detection of valve

    abscess (87% vs 28%)

  • 8/12/2019 Cardio_IE

    22/39

    Echocardiogram

    We generally perform a TTE as the first diagnostic testin most patients with suspected IE. However, it isreasonable to begin with TEE in selected settings: Limited transthoracic windows (eg, due to obesity, chest

    wall deformity, or mechanical ventilation) Prosthetic valves, especially prosthetic aortic or mitral

    valves in which shadowing may make visualization difficultby TTE

    A prior valvular abnormality (including previous

    endocarditis) S. aureus bacteremia

    Bacteremia due to an organism known to be a commoncause of IE such as viridans streptococci

  • 8/12/2019 Cardio_IE

    23/39

    Treatment

    Empiric therapy

    Should cover Staphylococcus, Streptococcus and

    Enterococcus

    Vancomycin 30 mg/kg per 24H IV in 2 divided

    doses

    Duration of therapy

    2-6 weeks

    Depends on organism, susceptibility, native vs

    prosthetic valve

  • 8/12/2019 Cardio_IE

    24/39

  • 8/12/2019 Cardio_IE

    25/39

  • 8/12/2019 Cardio_IE

    26/39

  • 8/12/2019 Cardio_IE

    27/39

  • 8/12/2019 Cardio_IE

    28/39

  • 8/12/2019 Cardio_IE

    29/39

  • 8/12/2019 Cardio_IE

    30/39

  • 8/12/2019 Cardio_IE

    31/39

  • 8/12/2019 Cardio_IE

    32/39

  • 8/12/2019 Cardio_IE

    33/39

  • 8/12/2019 Cardio_IE

    34/39

  • 8/12/2019 Cardio_IE

    35/39

  • 8/12/2019 Cardio_IE

    36/39

  • 8/12/2019 Cardio_IE

    37/39

    SURGERY IN NATIVE VALVE ENDOCARDITIS

    Heart failure, particularly if moderate to severe, thatis directly related to valve dysfunction

    Severe aortic or mitral regurgitation with evidence of

    abnormal hemodynamics such as premature closure

    of the mitral valve in patients with aortic

    insufficiency

    Endocarditis due to fungal or other highly resistant

    organisms Perivalvular infection with abscess or fistula

    formation

  • 8/12/2019 Cardio_IE

    38/39

    SURGERY FOR PROSTHETIC VALVE ENDOCARDITIS

    Heart failure Dehiscenceseen by cine fluoroscopy or

    echocardiography

    Evidence of increasing valve obstruction orworsening regurgitation

    Complications such as abscess formation

    Persistent bacteremia or recurrent emboli despite

    appropriate antibiotic therapy Relapsing infection

  • 8/12/2019 Cardio_IE

    39/39